Idev Technologies Incorporated


WEBSTER, Texas, November 10, 2011 - Lower Profile Provides Easier Operation, Improved Delivery Control and Efficiencies IDEV Technologies, Incorporated (IDEV), today announced the FDA has granted 510(k) clearance for the company's 6 French (6Fr) SUPERA VERITAS Transhepatic Biliary Stent System.

WEBSTER, Texas, July 12, 2011 - - Improved Operation and Control Make Stent Delivery More Efficient and Predictable IDEV Technologies, Incorporated (IDEV), today announced the first procedures in Europe utilizing the new 6 French (6Fr) SUPERA VERITAS Peripheral Vascular System.

WEBSTER, Texas, June 2, 2011 - - IDE Study Examines Performance of SUPERA(R) Stent in Superficial Femoral Artery (SFA) IDEV Technologies, Inc.

NOORDWIJKERHOUT, Netherlands and WEBSTER, Texas, May 17, 2011 - IDEV Technologies announced today that data from a long lesion study of 182 patients with significantly diseased superficial femoral arteries and popliteal arteries showed high patency rates and no stent fractures after treatment with the SUPERA VERITAS(R) Peripheral Vascular Stent System.
Older News
S M T W T F S
28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
Copyright© 2011 The Gaea Times